Plasma metanephrines in renal failure

Area of Science:

• Endocrinology
• Nephrology
• Clinical Diagnostics

Background:

• Pheochromocytoma diagnosis is challenging in renal failure due to unreliable urinary catecholamine tests.
• Plasma metanephrines (normetanephrine, metanephrine) offer an alternative diagnostic marker.
• The impact of renal insufficiency on plasma free vs. deconjugated metanephrine measurements is not well understood.

Purpose of the Study:

• To evaluate the reliability of plasma free and deconjugated metanephrines for diagnosing pheochromocytoma in patients with renal failure.
• To compare these measurements with catecholamine levels in various renal insufficiency states.

Main Methods:

• Plasma samples from 17 dialysis patients and 19 renal insufficiency patients were analyzed.
• Measurements included free and deconjugated metanephrines and catecholamines.
• Levels were compared to those in healthy individuals, hypertensives, and von Hippel-Lindau syndrome patients.

Main Results:

• Patients with renal failure showed elevated plasma catecholamines and free metanephrines, and significantly higher deconjugated metanephrines.
• Free metanephrine levels were within reference intervals for most renal failure patients.
• Deconjugated metanephrine levels were frequently outside reference intervals and inversely correlated with creatinine clearance.

Conclusions:

• Plasma free metanephrines are relatively independent of renal function, making them suitable for pheochromocytoma diagnosis in renal failure.
• Deconjugated metanephrine measurements are significantly influenced by renal insufficiency and less reliable for diagnosis in this population.